The aim of this study was to understand if the presence of a RHOA-G17V mutation in angioimmunoblastic T-cell lymphoma is responsible for the typical clinical presentation with early dissemination of tumor cells. This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.